HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-NOV-10 3POO TITLE HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 6-25; COMPND 11 SYNONYM: PKI-ALPHA, CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 12 MUSCLE/BRAIN ISOFORM; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKACA, PRKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS ATP BINDING, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.KOESTER,A.HEINE,G.KLEBE REVDAT 2 06-SEP-23 3POO 1 REMARK LINK REVDAT 1 16-NOV-11 3POO 0 JRNL AUTH H.KOESTER,T.CRAAN,A.HEINE,G.KLEBE JRNL TITL FRAGMENT BASED DRUG DESIGN ON PKA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.89 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 54627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 2744 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 26.8936 - 3.4449 0.93 5407 289 0.1793 0.2006 REMARK 3 2 3.4449 - 2.7352 0.98 5486 302 0.1907 0.2130 REMARK 3 3 2.7352 - 2.3897 0.97 5408 290 0.1869 0.2242 REMARK 3 4 2.3897 - 2.1713 0.97 5373 287 0.1747 0.1910 REMARK 3 5 2.1713 - 2.0157 0.98 5391 279 0.1773 0.2076 REMARK 3 6 2.0157 - 1.8969 0.96 5299 242 0.1781 0.2297 REMARK 3 7 1.8969 - 1.8019 0.92 5010 291 0.1882 0.2243 REMARK 3 8 1.8019 - 1.7235 0.91 4992 281 0.2047 0.2114 REMARK 3 9 1.7235 - 1.6572 0.89 4801 255 0.2205 0.2741 REMARK 3 10 1.6572 - 1.6000 0.86 4716 228 0.2530 0.2880 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 43.48 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.61240 REMARK 3 B22 (A**2) : -0.82660 REMARK 3 B33 (A**2) : -2.78580 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2956 REMARK 3 ANGLE : 0.993 4010 REMARK 3 CHIRALITY : 0.069 430 REMARK 3 PLANARITY : 0.005 510 REMARK 3 DIHEDRAL : 12.343 1072 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 14:72) REMARK 3 ORIGIN FOR THE GROUP (A): 35.3001 14.4495 4.9984 REMARK 3 T TENSOR REMARK 3 T11: 0.0032 T22: 0.1539 REMARK 3 T33: 0.1411 T12: -0.0226 REMARK 3 T13: -0.0384 T23: -0.0007 REMARK 3 L TENSOR REMARK 3 L11: 0.1776 L22: 0.9163 REMARK 3 L33: 0.8382 L12: 0.2925 REMARK 3 L13: -0.1651 L23: 0.7225 REMARK 3 S TENSOR REMARK 3 S11: -0.0153 S12: 0.0546 S13: 0.0535 REMARK 3 S21: 0.0380 S22: 0.0648 S23: -0.3407 REMARK 3 S31: -0.0166 S32: 0.3193 S33: -0.0241 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN A AND RESID 73:251) REMARK 3 ORIGIN FOR THE GROUP (A): 24.7530 1.6442 3.2476 REMARK 3 T TENSOR REMARK 3 T11: 0.0533 T22: 0.0492 REMARK 3 T33: 0.0495 T12: 0.0126 REMARK 3 T13: 0.0117 T23: 0.0174 REMARK 3 L TENSOR REMARK 3 L11: 0.6629 L22: 1.3997 REMARK 3 L33: 1.6286 L12: 0.3757 REMARK 3 L13: -0.0543 L23: 0.7609 REMARK 3 S TENSOR REMARK 3 S11: -0.0511 S12: -0.0161 S13: -0.0333 REMARK 3 S21: 0.1362 S22: -0.0183 S23: -0.1343 REMARK 3 S31: 0.2539 S32: 0.0681 S33: 0.0592 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: (CHAIN A AND RESID 252:350) REMARK 3 ORIGIN FOR THE GROUP (A): 27.3887 -3.6551 0.7170 REMARK 3 T TENSOR REMARK 3 T11: 0.2152 T22: 0.1459 REMARK 3 T33: 0.1673 T12: 0.0395 REMARK 3 T13: 0.0246 T23: -0.0021 REMARK 3 L TENSOR REMARK 3 L11: 0.7749 L22: 1.6998 REMARK 3 L33: 2.1081 L12: 0.3281 REMARK 3 L13: -0.0236 L23: 0.7286 REMARK 3 S TENSOR REMARK 3 S11: -0.0627 S12: 0.0443 S13: -0.1422 REMARK 3 S21: 0.1429 S22: 0.0439 S23: -0.1584 REMARK 3 S31: 0.4558 S32: 0.1386 S33: 0.0235 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: (CHAIN B AND RESID 1005:1022) REMARK 3 ORIGIN FOR THE GROUP (A): 13.9817 -1.9426 -10.4903 REMARK 3 T TENSOR REMARK 3 T11: 0.2410 T22: 0.1932 REMARK 3 T33: 0.1558 T12: -0.0448 REMARK 3 T13: 0.0351 T23: -0.0094 REMARK 3 L TENSOR REMARK 3 L11: 0.0668 L22: 0.4596 REMARK 3 L33: 0.0986 L12: -0.0952 REMARK 3 L13: 0.0363 L23: -0.1595 REMARK 3 S TENSOR REMARK 3 S11: -0.0126 S12: -0.0252 S13: -0.0242 REMARK 3 S21: -0.0082 S22: -0.1226 S23: -0.0359 REMARK 3 S31: 0.0889 S32: -0.0502 S33: 0.1143 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3POO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000062631. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR KMC REMARK 200 -2 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57573 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03900 REMARK 200 FOR THE DATA SET : 26.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.49600 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1OEW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5MM MES, 5MM BISTRIS-PROPANE, 75MM REMARK 280 LICL, 1ML DTT, 0.1MM EDTA EQUILIBRATED AGAINST WATER/ETHANOL, PH REMARK 280 6.9, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.43500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.47000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.43500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.47000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 GLN A 12 REMARK 465 GLU A 13 REMARK 465 LYS A 319 REMARK 465 GLY A 320 REMARK 465 PRO A 321 REMARK 465 GLY A 322 REMARK 465 ASP B 24 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 GLU A 24 CG CD OE1 OE2 REMARK 470 LYS A 28 CG CD CE NZ REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 470 LYS A 217 CG CD CE NZ REMARK 470 ILE A 244 CG1 CG2 CD1 REMARK 470 GLN A 245 CG CD OE1 NE2 REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 295 CG CD CE NZ REMARK 470 LYS A 309 CG CD CE NZ REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 PHE A 318 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 LYS A 345 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 99 105.22 -160.34 REMARK 500 ASP A 166 42.06 -148.80 REMARK 500 ASP A 184 86.58 59.44 REMARK 500 LEU A 273 49.92 -87.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE S69 A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BUD A 3001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3NX8 RELATED DB: PDB REMARK 900 HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL REMARK 900 RELATED ID: 3OOG RELATED DB: PDB REMARK 900 HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT REMARK 900 RELATED ID: 3OVV RELATED DB: PDB REMARK 900 HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 3OXT RELATED DB: PDB REMARK 900 HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 3OWP RELATED DB: PDB REMARK 900 HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 3P0M RELATED DB: PDB REMARK 900 HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR DBREF 3POO A 0 350 UNP P17612 KAPCA_HUMAN 1 351 DBREF 3POO B 5 24 UNP P61925 IPKA_HUMAN 6 25 SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN SEQRES 15 A 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP MODRES 3POO TPO A 197 THR PHOSPHOTHREONINE MODRES 3POO SEP A 338 SER PHOSPHOSERINE HET TPO A 197 11 HET SEP A 338 10 HET S69 A2001 23 HET BUD A3001 6 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM S69 N'-[(E)-(2,4-DIHYDROXY-6-METHYLPHENYL)METHYLIDENE]-2- HETNAM 2 S69 (3-METHOXYPHENYL)ACETOHYDRAZIDE HETNAM BUD (2S,3S)-BUTANE-2,3-DIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 S69 C17 H18 N2 O4 FORMUL 4 BUD C4 H10 O2 FORMUL 5 HOH *248(H2 O) HELIX 1 1 SER A 14 SER A 32 1 19 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 GLY A 253 1 12 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 THR B 5 ALA B 12 1 8 SHEET 1 A 5 PHE A 43 GLY A 52 0 SHEET 2 A 5 GLY A 55 HIS A 62 -1 O VAL A 57 N LEU A 49 SHEET 3 A 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 A 5 ASN A 115 GLU A 121 -1 O MET A 120 N ALA A 70 SHEET 5 A 5 LEU A 106 LYS A 111 -1 N PHE A 110 O TYR A 117 SHEET 1 B 2 LEU A 162 ILE A 163 0 SHEET 2 B 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 C 2 LEU A 172 ILE A 174 0 SHEET 2 C 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 SITE 1 AC1 16 GLY A 52 SER A 53 PHE A 54 GLY A 55 SITE 2 AC1 16 VAL A 57 ALA A 70 LYS A 72 MET A 120 SITE 3 AC1 16 GLU A 121 TYR A 122 VAL A 123 LEU A 173 SITE 4 AC1 16 THR A 183 ASP A 184 HOH A5112 HOH A5122 SITE 1 AC2 6 THR A 51 GLY A 52 HOH A5127 HOH A5146 SITE 2 AC2 6 ARG B 19 ASN B 20 CRYST1 72.870 74.940 79.700 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013723 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013344 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012547 0.00000